2017_IGRT course book
National Trial
62 patients with pT2-T4a N0 M0 bladder carcinoma unsuitable for standard daily radiotherapy
Due to receive six 6Gy fractions of radiotherapy delivered weekly (total dose: 36Gy over 6 weeks)
RANDOMISE 1:1
Group 1: STANDARD PLANNING (CONTROL)
Group 2: ADAPTIVE PLANNING (EXPERIMENTAL)
Follow up • Weekly on treatment • 4 weeks after last treatment • 3 months after last treatment • 6, 12 and 24 months
in partnership with
Made with FlippingBook - Online catalogs